Jura Health

04/20/2026

10/16/2025

Hide your beignets, Jura Health is coming to Louisiana!

Jura Health has been welcomed by Louisiana Medicaid as an approved provider for suspected Rare Diseases testing.

Jura Health’s Emerge™ Platform provides whole genome sequencing (WGS), genetic counseling, and next step support; providing a personalized plan for individuals facing the complexities of rare genetic disorders. The average time to a diagnosis for a rare disease patient is 6 years. Jura Health’s aim is to reduce that to 1 month. This Medicaid expansion ensures that more people in Louisiana can access essential diagnostic and support services that can significantly improve their care journey.

We're also approved in CO with more states coming!

Come visit us at http://jura.health

06/24/2025

BREAKING NEWS: According to a new report from the American Academy of Pediatrics (AAP), clinicians should prioritize genetic testing for young children who show signs of intellectual disability or developmental delays. They also stress the importance of pre-test genetic counseling, a service Jura Health offers FREE with every test.

The American Academy of Pediatrics’ June 23, 2025 clinical report urges general pediatricians to use a genetics first approach when evaluating children with intellectual disability or global developmental delay. It recommends beginning with detailed phenotype-driven assessment—examining history,

06/12/2025

At Jura Health, we’ve made world-class genomic testing available across Colorado and are excited to expand to other states soon to help more kids like this get the testing they need and connect them to world class treatments.

The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases.

06/12/2025

Want to learn more about genetic testing for Rare Diseases? Come check us out at https://www.jura.health/startorder

03/21/2025

https://www.jura.health/blog/why-whole-genome-sequencing-is-better-than-whole-exome-sequencing-for-rare-diseases

WGS improves diagnostic yield over WES by approximately 50% to 140% , because WGS captures both coding and non-coding regions. Although WGS currently costs roughly 1.5 to 2 times more than WES—it often yields a higher diagnostic rate, reducing downstream testing and speeding time to diagnosis. In ...

03/21/2025

Learn about the value of Whole Genome Sequencing (WGS) for rare diseases. WGS reads over 98% of your DNA, compared to about 1–2% covered by exome sequencing, giving it a much broader view of your genetic makeup. This means WGS can uncover hard-to-find answers in rare disease cases, making it a powerful tool for families searching for answers. Jura Health only offers WGS to it's community because we understand the power of the entire genome. hashtag hashtag hashtag

08/13/2024

"One of the most significant moments you can experience...is getting a diagnosis." opens up about his eldest son's rare disease and the foundation he's started to support those with intellectual disabilities and the families who love and care for them.
What an amazing dad!!
https://lnkd.in/gTdHNHgv


https://www.youtube.com/watch?app=desktop&v=JDiD8Z3lWQk&t=120s&t=2m

Colin Farrell opens up for the first time about life with his 20-year-old son, James, who has a rare debilitating disorder called Angelman syndrome and why h...

06/27/2024

(The authors) hope their study will encourage other clinicians to use — and insurance to cover — (whole) genome sequencing as a first-line test for patients with rare diseases. While costs and payer reimbursement vary, the incremental cost of genome versus exome sequencing is not substantial and can save money by avoiding the need for other testing.

New work makes the case for early genome sequencing, which can make diagnoses not possible any other way in patients with rare disease.

06/26/2024

We are very excited to announce that Jura Health has been selected to advance as a Semifinalist in the 2024 Prime Health Innovation Challenge in Colorado! Prime Health’s Innovation Challenge is an annual program that advances healthcare through innovation, aiming to improve health equity, access, quality, and cost for underserved communities in California and Colorado. hashtag
Prime Health